全文获取类型
收费全文 | 3772篇 |
免费 | 285篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 126篇 |
妇产科学 | 126篇 |
基础医学 | 362篇 |
口腔科学 | 72篇 |
临床医学 | 548篇 |
内科学 | 560篇 |
皮肤病学 | 45篇 |
神经病学 | 254篇 |
特种医学 | 361篇 |
外科学 | 501篇 |
综合类 | 271篇 |
一般理论 | 7篇 |
预防医学 | 361篇 |
眼科学 | 32篇 |
药学 | 244篇 |
2篇 | |
中国医学 | 32篇 |
肿瘤学 | 154篇 |
出版年
2022年 | 38篇 |
2021年 | 62篇 |
2020年 | 47篇 |
2019年 | 43篇 |
2018年 | 56篇 |
2017年 | 53篇 |
2016年 | 47篇 |
2015年 | 65篇 |
2014年 | 86篇 |
2013年 | 155篇 |
2012年 | 168篇 |
2011年 | 180篇 |
2010年 | 157篇 |
2009年 | 168篇 |
2008年 | 160篇 |
2007年 | 161篇 |
2006年 | 164篇 |
2005年 | 128篇 |
2004年 | 136篇 |
2003年 | 126篇 |
2002年 | 116篇 |
2001年 | 104篇 |
2000年 | 107篇 |
1999年 | 80篇 |
1998年 | 95篇 |
1997年 | 88篇 |
1996年 | 87篇 |
1995年 | 73篇 |
1994年 | 49篇 |
1993年 | 57篇 |
1992年 | 51篇 |
1991年 | 49篇 |
1990年 | 37篇 |
1989年 | 62篇 |
1988年 | 66篇 |
1987年 | 55篇 |
1986年 | 44篇 |
1985年 | 58篇 |
1984年 | 33篇 |
1983年 | 33篇 |
1982年 | 28篇 |
1980年 | 32篇 |
1979年 | 24篇 |
1978年 | 31篇 |
1977年 | 27篇 |
1959年 | 24篇 |
1958年 | 29篇 |
1956年 | 31篇 |
1955年 | 42篇 |
1954年 | 35篇 |
排序方式: 共有4103条查询结果,搜索用时 15 毫秒
1.
Dr. Arni Raghavendrarao Raghuram M.Ch. Subbiah Kumar MD Kathamuthu Balamurugan DA Arulmurugan DA Ramiah Krishnan M.Ch. Perichiappan Sivakami BS Eluvathingal Varghese John M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(3):178-181
Background Beating heart surgery has now become the commonest technique of doing Coronary Artery Bypass Graft Surgery (CABG) in our country.
It is being used even in such high risk situations like diffuse coronary disease and Critical Left Main stem Stenosis (LMCS)
with good results. The aim of this study is to retrospectively review our results in Off-Pump Coronary Artery Bypass Surgery
(OPCAB) in patients with critical left main stem stenosis.
Methods This study is a retrospective analysis of the data of patients who underwent primary coronary artery bypass surgery. During
the period from April 2003 to September 2005 a total of 64 patients underwent OPCAB procedure for critical LMCS. During the
same period 10 patients underwent CABG on Cardio Pulmonary Bypass (CPB). The age range was 36–77yrs. The sex distribution
was M: F 53∶10. Ten patients were done as emergency. 2 of them were on Intra Aortic Balloon Pump (IABP) support preoperatively.
10 patients were high risk with a Euro score of ≥5.
Results Left Internal Mammary Artery (LIMA) was used in 78% of cases. Average grafts per patient was 2.96. The median ventilation
time was 5.91 hrs. New IABP insertion in postoperative period was required in 1 patient. One patient was reexplored for bleeding.
There was one perioperative myocardial infarction. 57% of patients did not need any blood transfusion. There was no conversion
to CPB. There was no operative mortality. Inotropes were used in ten cases.
Conclusions OPCAB is a safe method of revascularization in patients with critical LMCS. Preoperative IABP is useful in patients with cardiogenic
shock. However, there is a place for CPB in patients needing additional procedures like Mitral Valve repair (MV repair) or
Dor's procedure or when the vessels are very diffusely diseased. Those patients who are unstable despite IABP support may
be managed by Beating heart On Pump (BHOP) technique. 相似文献
2.
RenNew-D (Alcide), a novel demand-release sporocidal agent, was employed instead of formaldehyde in the reprocessing for reuse of cuprophan hollow fiber dialyzers (Gambro) and the performance of these dialyzers was evaluated over 40 consecutive dialyses in six patients on maintenance hemodialysis. When RenNew-D was part of automated reprocessing performed with 4.3% bleach as specified by the manufacturer (Lixivitron), dialyzer survival was prolonged (16.7 +/- 7.2 uses) and hemodialysis neutropenia was unchanged with reuse. When RenNew-D was part of manual reprocessing conducted in the absence of bleach, marked improvement in dialyzer biocompatibility was observed but with a decreased survival (4.8 +/- 3.0). The majority of dialyzer failures were due to a fall in fiber bundle volume below a 85% set limit. Small solute clearances were maintained with both types of reprocessing. Dialyses were well tolerated throughout. Our data suggest that RenNew-D is a safe and efficacious product which can serve as a valuable alternative to formaldehyde for the purpose of dialyzer reuse. 相似文献
3.
4.
5.
6.
Dr. James C. Garrelts Pharm.D. W. Dale Horst Ph.D. Beryl Silkey Sc.M. Dr. Suzanne Gagnon M.D. 《Pharmacotherapy》1994,14(4):438-445
Study Objectives . To characterize patient sociodemographics and health, describe vancomycin treatment parameters and clinician-rated outcomes, and determine costs associated with treatment including preparation and administration, adverse events, and toxicity. Design . A prospective study to develop a model for costs associated with antibiotic treatment (vancomycin). Setting . A community hospital. Patients . One hundred adults with active infections. Interventions . Mean duration of therapy was 10 days, and most patients received 2000 mg/day. Serum concentrations were monitored in two of three patients. Detailed cost analyses were completed on a subset of 26 patients selected at random from the overall sample. Measurements and Main Results . Sepsis and skin and skin structure infections were the most common indications for vancomycin therapy. Treatment was effective in 81 patients, failed in 9, and was not evaluable in 10. Thirty-eight percent of patients experienced adverse events attributable to the drug. Phlebitis was common, and red man syndrome, nephrotoxicity, and ototoxicity were infrequent. Conclusions . Total cost of vancomycin treatment for 100 patients was $30,251: $23,855 for preparation and administration, $1710 for monitoring serum concentrations, and $4686 for treating adverse reactions. Drug costs accounted for only 55% of the total cost. Vancomycin is safe and effective, but phlebitis is underreported and significantly affects cost. 相似文献
7.
Philip Peng FRCPC Manon Choiniere PhD Dominique Dion MD MSc Howard Intrater FRCPC Sandra LeFort PhD Mary Lynch FRCPC May Ong FRCPC Saifee Rashiq MSc DA FRCPC Gregg Tkachuk PhD Yves Veillette FRCPC 《Journal canadien d'anesthésie》2007,54(12):977-984
PURPOSE: The objective of this survey was to examine the services offered by multidisciplinary pain treatment facilities (MPTFs) across Canada and to compare access to care at these MPTFs. METHODS: A MPTF was defined as a clinic that advertised specialized multidisciplinary services for the diagnosis and management of patients with chronic pain, having a minimum of three different health care disciplines (including at least one medical speciality) available and integrated within the facility. The search method included approaching all hospital and rehabilitation centre administrators in Canada, the Insurance Bureau of Canada, the Workplace Safety and Insurance Board or similar body in each province. Designated investigators were responsible for confirming and supplementing MPTFs from the preliminary list for each province. Administrative leads at each eligible MPTF were asked to complete a detailed questionnaire regarding their MPTF infrastructure, clinical, research, teaching and administrative activities. RESULTS: Completed survey forms were received from 102 MPTFs (response rate 85%) with 80% concentrated in major cities, and none in Prince Edward Island and the Territories. The MPTFs offer a wide variety of treatments including non-pharmacological modalities such as interventional, physical and psychological therapy. The median wait time for a first appointment in public MPTFs is six months, which is approximately 12 times longer than non-public MPTFs. Eighteen pain fellowship programs exist in Canadian MPTFs and 64% engage in some form of research activities CONCLUSION: Canadian MPTFs are unable to meet clinical demands of patients suffering from chronic pain, both in terms of regional accessibility and reasonable wait time for patients' first appointment. 相似文献
8.
9.
10.
DA Taylor 《Environmental health perspectives》2002,110(9):A512-A513